K-numberK252056
Device nameIsolator® Synergy™ EnCompass Clamp and Guide system (OLH, OSH, GPM100)
ApplicantAtriCure, Inc.
Product codeOCL
Device classClass II
Decision dateJul 24, 2025
DecisionSubstantially Equivalent
Regulation878.4400
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Isolator Synergy EnCompass Clamp and Guide System is a single-use electrosurgical surgical instrument designed to ablate cardiac tissue during surgery. It consists of two clamp configurations (OLH and OSH) with different jaw lengths, each supplied with a Glidepath Magnetic Guide (GPM100), and delivers radiofrequency energy via a reusable bipolar generator to create transmural lesions in cardiac tissue.

Technological characteristics

The device maintains the same fundamental vascular clamp design, hexagonal jaw configuration, inline syringe-type handle, and dual electrode pairs as the predicate. Minor changes include: conversion of D-shaped magnet cups at jaw tips to cylindrical magnet cups for improved connection to the Guide; minor jaw and insulator geometry modifications to accommodate overmolding and metal-injection molding manufacturing processes; and tapering of the Guide's red santoprene end portions while maintaining overall length.

Test standards cited

ISO 10993-1:2018 (biocompatibility evaluation); IEC 60601-1:2005+A1:2012+A2:2020 Ed. 3.2 (electrical safety); IEC 60601-2-2:2014+A1:2020 (medical electrical equipment); ANSI/AAMI/ISO 11135 (ethylene oxide sterilization validation); ANSI/AAMI/ISO 10993-7 (EO sterilization residuals).

Substantial equivalence argument

The fundamental design, technology, function, operating principle, and intended use remain identical to the predicate device. Ex vivo ablation testing with bovine tissue demonstrated the subject device creates transmural lesions in substantially equivalent manner to the predicate. Lifecycle testing confirmed design life is unaffected by changes. Usability testing in cadaver models showed zero use errors and no new risks introduced. All technological modifications—magnet cup shape change, jaw geometry refinement, and Guide tapering—are minor design optimizations that do not alter device function or safety; they accommodate improved manufacturing processes while maintaining the same connection strength and overall performance characteristics.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →